Delivery Order SPE2DB20D1100-SPE2DB25FA8N9
Award Date
2/28/25
Potential Completion Date
3/3/25
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML medical products. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $21,986.28 and a performance period through January 8, 2025. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,859.06 firm fixed-price delivery order is for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML medical products. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a $4,695.66 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product, with a period of performance through March 3, 2025. The contract is a firm fixed price, Indefinite Delivery Contract (IDC) without any set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 IDC with the DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of an autoinjector product (ADBRY 300 MG/2 ML AUTOINJECTOR 2ML) with a ceiling value of $19,912.70 and a period of performance through February 2025. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and...
This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,159.00, is a delivery order that provides the ADBRY 300 MG/2 ML AUTOINJECTOR 2ML pharmaceutical product. It has a performance period through November 1, 2024 and uses a firm fixed price pricing arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award for $5,364.44 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medical product "ADBRY 150 MG/ML SYRINGEML" with a completion date of May 23, 2024. The contract is a firm fixed price award with no set-aside designation, indicating open competition. AmerisourceBergen holds a substantial Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,364.74 firm-fixed-price delivery order contract is for the provision of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. This award is under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award, valued at $5,617.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADBRY 150 MG/ML syringes and has an ultimate completion date of August 7, 2023. The contract type is Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,525.37, is for the delivery of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with an ultimate completion date of May 9, 2023. The contract is not designated with a set-aside, indicating open competition....
This federal contract award, valued at $2,041.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025 and is a Firm Fixed Price contract. The award was not designated with a set-aside requirement, indicating open competition....